Christopher C. Caillouet

Array ( [id] => 1216908 [patent_doc_number] => 06706741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Acetylcholinesterase inhibitors containing 1-benzyl-pyridinium salts' [patent_app_type] => B2 [patent_app_number] => 10/221963 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4774 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706741.pdf [firstpage_image] =>[orig_patent_app_number] => 10221963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865543 [patent_doc_number] => 20030191069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => '2-oxoquinoline compounds and pharmaceutical uses thereof' [patent_app_type] => new [patent_app_number] => 10/245861 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25016 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191069.pdf [firstpage_image] =>[orig_patent_app_number] => 10245861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597487 [patent_doc_number] => 07619090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Monocyclopentadienyl complexes comprising a condensed heterocycle' [patent_app_type] => utility [patent_app_number] => 10/489023 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15302 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/619/07619090.pdf [firstpage_image] =>[orig_patent_app_number] => 10489023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150595 [patent_doc_number] => 06770661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Aryl substituted pyridines and their use' [patent_app_type] => B2 [patent_app_number] => 10/235670 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9529 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 258 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770661.pdf [firstpage_image] =>[orig_patent_app_number] => 10235670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265392 [patent_doc_number] => 20040242928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Reverse hydroxamic acid derivatives' [patent_app_type] => new [patent_app_number] => 10/488530 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59182 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242928.pdf [firstpage_image] =>[orig_patent_app_number] => 10488530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228786 [patent_doc_number] => 06696471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Aminopyrrole compounds' [patent_app_type] => B2 [patent_app_number] => 10/231792 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7585 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696471.pdf [firstpage_image] =>[orig_patent_app_number] => 10231792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1179013 [patent_doc_number] => 06743919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => '2-aroylimidazole compounds for treating cancer' [patent_app_type] => B2 [patent_app_number] => 10/233371 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16656 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743919.pdf [firstpage_image] =>[orig_patent_app_number] => 10233371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669503 [patent_doc_number] => 20030114487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Enantiomers of 6-[(4-chloro-phenyl)- hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1- methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/228657 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12683 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114487.pdf [firstpage_image] =>[orig_patent_app_number] => 10228657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347330 [patent_doc_number] => 20040192725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/487588 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18772 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192725.pdf [firstpage_image] =>[orig_patent_app_number] => 10487588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745909 [patent_doc_number] => 20030023092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/227402 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10499 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023092.pdf [firstpage_image] =>[orig_patent_app_number] => 10227402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 708223 [patent_doc_number] => 07060834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'N-type calcium channel antagonists for the treatment of pain' [patent_app_type] => utility [patent_app_number] => 10/488066 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8337 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060834.pdf [firstpage_image] =>[orig_patent_app_number] => 10488066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098561 [patent_doc_number] => 20050131020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'N-type calcium channel antagonists for the treatment of pain' [patent_app_type] => utility [patent_app_number] => 10/488025 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8518 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131020.pdf [firstpage_image] =>[orig_patent_app_number] => 10488025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7398481 [patent_doc_number] => 20040039026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Cyclopropyl and cyclobutyl epothilone analogs' [patent_app_type] => new [patent_app_number] => 10/227073 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11018 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20040039026.pdf [firstpage_image] =>[orig_patent_app_number] => 10227073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314711 [patent_doc_number] => 20040034092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2\' hydroxyflavonoids' [patent_app_type] => new [patent_app_number] => 10/223811 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9939 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034092.pdf [firstpage_image] =>[orig_patent_app_number] => 10223811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1213651 [patent_doc_number] => 06710205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-23 [patent_title] => 'Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient' [patent_app_type] => B2 [patent_app_number] => 10/204049 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12192 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/710/06710205.pdf [firstpage_image] =>[orig_patent_app_number] => 10204049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730711 [patent_doc_number] => 20030186901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Method of inhibiting neurotrophin-receptor binding' [patent_app_type] => new [patent_app_number] => 10/219319 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16108 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186901.pdf [firstpage_image] =>[orig_patent_app_number] => 10219319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1320521 [patent_doc_number] => 06605722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Tyrosine derivatives with anti-leukotrienen activity' [patent_app_type] => B2 [patent_app_number] => 10/203424 [patent_app_country] => US [patent_app_date] => 2002-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4175 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 260 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605722.pdf [firstpage_image] =>[orig_patent_app_number] => 10203424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224163 [patent_doc_number] => 06699877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives' [patent_app_type] => B2 [patent_app_number] => 10/213436 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19720 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 857 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699877.pdf [firstpage_image] =>[orig_patent_app_number] => 10213436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721569 [patent_doc_number] => 20030055259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Method for producing 5-aryl nicotinaldehydes' [patent_app_type] => new [patent_app_number] => 10/203159 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2952 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055259.pdf [firstpage_image] =>[orig_patent_app_number] => 10203159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1157256 [patent_doc_number] => 06765105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-20 [patent_title] => 'Compound and pharmaceutical composition of antiplasmid effect and the preparation thereof' [patent_app_type] => B2 [patent_app_number] => 10/048561 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4137 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/765/06765105.pdf [firstpage_image] =>[orig_patent_app_number] => 10048561 [rel_patent_id] =>[rel_patent_doc_number] =>)